2026 Updated EBMT/ESID inborn errors working party guidelines for haematopoietic stem cell transplantation for inborn errors of immunity and metabolism Group Inborn Errors Working Party (IEWP) 1st listed author M H Albert Journal Bone Marrow Transplant.
2026 The impact of pre-transplant extramedullary disease on the outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in children- on behalf of PDWP/EBMT Group Paediatric Diseases Working Party (PDWP) 1st listed author Juliana Silva Journal Bone Marrow Transplant.
2026 Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimaging Group Practice Harmonisation and Guidelines Committee 1st listed author Martin Schmidt-Hieber Journal Bone Marrow Transplant.
2026 Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committee Group Practice Harmonisation and Guidelines Committee 1st listed author Roser Velasco Journal Bone Marrow Transplant.
2026 Impact of donor and recipient EBV serostatus on transplant outcomes in patients with acute leukemia after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: Infectious Diseases Working Party EBMT retrospective study Group Infectious Diseases Working Party (IDWP) 1st listed author Jan Styczynski Journal Bone Marrow Transplant.
2026 Outcomes of patients over 70 years treated with brexu-cel for R/R mantle cell lymphoma: a study from the CTIWP of EBMT Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Nicole Santoro Journal Blood Adv.
2026 Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia - a study on behalf of the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Joanna Drozd-Sokolowska Journal Haematologica.
2026 Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP) Group Acute Leukemia Working Party (ALWP) Paediatric Diseases Working Party (PDWP) 1st listed author Fabio Andreozzi Journal Bone Marrow Transplant.
2026 Survey on ICU organization and admission after hematopoietic cell transplantation - a report by IDWP and TCWP of the EBMT Group Infectious Diseases Working Party (IDWP) Complications Working Party (CWP) 1st listed author Joanna Drozd-Sokolowska Journal Bone Marrow Transplant.
2026 Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee Group Practice Harmonisation and Guidelines Committee 1st listed author Christopher Armstrong Journal Bone Marrow Transplant.
2026 Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Alexandros Kanellopoulos Journal Bone Marrow Transplant.
2026 Bridging therapy before CAR-T for multiple myeloma: a survey from the CMWP and CTIWP of the EBMT Group Chronic Malignancies Working Party (CMWP) Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Nico Gagelmann Journal Bone Marrow Transplant.